Skip to main content
. 2019 Aug 1;42(10):1921–1929. doi: 10.2337/dc19-0937

Figure 1.

Figure 1

eGFR change over time in overall population. LS mean (LSM) change from baseline (BL) vs. placebo at week 52 for SOTA 200 mg, −1.96 mL/min/1.73 m2 (95% CI −3.45, −0.47), P = 0.010, and SOTA 400 mg, −0.49 mL/min/1.73 m2 (−1.99, 1.00), P = 0.52.